Jennifer Miller

See the following -

Hackers Created a $30 DIY Version of the EpiPen

Ephrat Livni | Quartz | September 27, 2016

The EpiPen is a potentially life-saving device for those with severe allergies or asthma. The problem is that it costs $600 in the US. For those with or without respiration woes, the EpiPen represents what’s wrong with drug manufacturing nationally, namely high prices and manufacturer monopolies. Mylan, maker of the EpiPen, raised the device’s price 300% in seven years from 2009 to 2016, mostly because it could...

Read More »

Nature Journal on the Need for Clinical-Trial Data Sharing Regulations

Editorial | Nature | May 17, 2016

Governments need to tighten regulation if the sharing of clinical-trial data is to succeed. Clinical science has a compatibility problem. Although there are set protocols to test medicines and to treat patients, no such standards exist to compare clinical-trial data. The problem arises because each research group has a preferred method of collecting and categorizing results. Differences can be as great as omitting or including the gender and ethnicity of patients enrolled, or as mundane as the vocabulary used in medical records...

Read More »